In Brief: FDA Office of Generic Drugs
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of Generic Drugs: Allen Rudman, PhD, appointed deputy director of OGD's Division of Chemistry I. He replaces Frank Holcombe, PhD, who left to become director of OGD's Division of Chemistry II on Aug. 5. Rudman has been an OGD chemistry reviewer since September 1991, FDA says, with 18 years prior experience in industry..
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning